|
|
 | | From: | ironjustice at aol.com | | Subject: | First and Only Clinically Tested Antioxidant Cream | | Date: | 20 Jan 2005 12:43:50 -0800 |
|
|
 | http://tinyurl.com/5wypq
January 04, 2005 08:15 AM US Eastern Timezone
Allergan Launches PREVAGE-TM- Antioxidant Cream, the First and Only
Clinically Tested Antioxidant That Corrects and Protects the Skin
IRVINE, Calif.--(BUSINESS WIRE)--Jan. 4, 2005--Allergan, Inc.
(NYSE:AGN) today announced the launch of PREVAGE(TM) antioxidant cream,
the first and only clinically tested antioxidant that not only reduces
the appearance of fine lines and wrinkles, but also provides protection
against environmental factors including sun damage, air pollution and
cigarette smoke.(1)
Representing the next generation of antioxidants, PREVAGE(TM)
antioxidant cream is a novel cosmeceutical containing 1 percent
idebenone - a revolutionary, potent and effective new antioxidant.
"We had sun block in the seventies and glycolic acids in the eighties,
and now we have PREVAGE(TM) antioxidant cream, the first advance we
have seen in decades that is backed by scientific studies," said
Jeanine B. Downie, M.D., Director of Image Dermatology, Montclair, New
Jersey. "PREVAGE(TM) antioxidant cream is a potent antioxidant that is
clinically proven to not only protect the skin against sun damage and
the environment, but also to correct fine lines and wrinkles."
Proven Scientific Evidence
Data that compare leading antioxidants show that idebenone is the most
effective topical antioxidant product available.(1) A six-week clinical
study evaluated the use of PREVAGE(TM) antioxidant cream containing a 1
percent concentration of idebenone in 21 women between the ages of 18
and 65 with moderate photoaging (dry facial skin and fine
lines/wrinkles). The women in the study applied PREVAGE(TM) antioxidant
cream twice a day to the facial area for six weeks. Study results
included:
-- 29 percent reduction in the appearance of fine lines and wrinkles;
-- 26 percent reduction in skin roughness or dryness;
-- 37 percent increase in skin hydration; and,
-- 33 percent overall global improvement in the appearance of skin.(2)
"While other creams just sit on the skin's surface, the unique
formulation of PREVAGE(TM) antioxidant cream allows it to penetrate the
skin at the cellular level to help prevent free radicals from breaking
down the collagen and elastin in the skin," added Dr. Downie.
"PREVAGE(TM) antioxidant cream is the newest addition to our
dermatology franchise," said Bob Rhatigan, Vice President, Allergan's
U.S. Dermatology business unit. "With a rich heritage in skincare, we
are excited to continue providing dermatologists and plastic surgeons
with products supported by science and proven results."
PREVAGE(TM) antioxidant cream is available exclusively through
dermatologists' and plastic surgeons' offices. To locate an office or
for more information, please visit www.prevage.com.
About Idebenone
When compared to other commonly known topical antioxidants available in
skincare products, idebenone is the most potent and effective
antioxidant compound. Idebenone has been found to be effective in
protecting the skin against key environmental stressors known to cause
fine lines and wrinkles including: ultraviolet radiation, ozone, air
pollution and cigarette smoke. It also was ranked the most effective
compound tested in a series of biochemical and cell-biological methods
used to determine the effectiveness of antioxidant compounds at
preventing biological damage as a result of oxidative stress.(1)
A close relative of the compound Co-Enzyme Q10, idebenone has far
greater skin penetration potential and a much higher oxidative stress
protection capacity.(1) Its lower molecular weight allows for greater
skin penetration and extended shelf life stability.
About Allergan, Inc.
Allergan, Inc., with headquarters in Irvine, California, is a
technology-driven, global health care company providing specialty
pharmaceutical products worldwide. Allergan develops and commercializes
products in the eye care, neuromodulator, skin care and other specialty
markets that deliver value to its customers, satisfy unmet medical
needs, and improve patients' lives.
Forward-Looking Statements
This press release contains "forward-looking statements," including the
statements by Dr. Downie and other statements regarding the
effectiveness of PREVAGE(TM) antioxidant cream. These statements are
based on current expectations of future events. If underlying
assumptions prove inaccurate or unknown risks or uncertainties
materialize, actual results could vary materially from Allergan's
expectations and projections. Risks and uncertainties include, among
other things, general industry and pharmaceutical market conditions;
general domestic and international economic conditions, such as
interest rate and currency exchange rate fluctuations; technological
advances and patents attained by competitors; challenges inherent in
the research and development and regulatory processes; challenges
related to new product marketing, such as the unpredictability of
market acceptance for new pharmaceutical and biologic products and/or
the acceptance of new indications for such products; potential
difficulties in manufacturing a new product formulation; domestic and
foreign health care reforms; trends toward managed care and health care
cost containment; and governmental laws and regulations affecting
domestic and foreign operations. Additional information concerning
these and other risk factors can be found in press releases issued by
Allergan, as well as Allergan's public periodic filings with the
Securities and Exchange Commission, including the discussion under the
heading "Certain Factors and Trends Affecting Allergan and its
Businesses" in Allergan's 2003 Form 10-K and Allergan's Form 10-Q for
the quarter ended March 26, 2004. Copies of Allergan's press releases
and additional information about Allergan is available on the World
Wide Web at www.allergan.com or you can contact the Allergan Investor
Relations Department by calling 1-714-246-4636.
(1) 2004 AAD Poster Exhibit: Antioxidants Compared in a New Protocol
to Measure Protective Capacity Against Oxidative Stress - Part II;
DiNardo, J., Lewis, J., Neudecker, B., Dimitar, B., Wieland, E.,
Maibach, H.
(2) Six Week Clinical Evaluation of PREVAGE(TM) for the Treatment of
Photoaging; DiNardo, J.
Contacts
Allergan, Inc., Irvine
Jim Hindman (Investors), 714-246-4636
Joann Bradley (Investors), 714-246-4766
Ashwin Agarwal (Investors), 714-246-4582
Stephanie Fagan (Media), 714-246-5232
Who loves ya.
Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking
|
|
| | From: | Joseph | | Subject: | Re: Markers for Low IQ (Re: First and Only ...) | | Date: | 23 Jan 2005 15:49:31 -0800 |
|
|
| I have this theory about people in the first quantile of intelligence
scores. They are, like, all obsesed about intelligence and IQ. And
money.
It's funny. They really don't like taking care of themselves, and being
responsible and stuff, but they all think they do, and talk and vote
that way.
Weird, huh?
They also like those girls who wear Abercrombie. As if.
|
|
| | From: | Mr-Natural-Health | | Subject: | Markers for Low IQ (Re: First and Only ...) | | Date: | 23 Jan 2005 14:03:45 -0800 |
|
|
| ironjustice@aol.com wrote: Blah, ...Blah, Blah!
I have this theory about people in the first quantile of intelligence
scores. They all use AOL as their ISP. Use of AOL is a good marker
for a Low IQ.
AOL is for those who need to be protected from themselves.
Unfortunately, the rest of humanity offen needs to be protected from
AOL usere. Why are you paying $25 for a service that is going for $10
everywhere else?
What makes you think that anybody is interest in your constant babbling
about dribble? Please stop posting your mental confusion on smn!!!
..
You have my condolences.
|
|
|
